Clinical tools to predict outcomes in patients with esophageal cancer treated with definitive chemoradiation: Are we there yet? Journal Article


Authors: Wu, A. J.; Goodman, K. A.
Article Title: Clinical tools to predict outcomes in patients with esophageal cancer treated with definitive chemoradiation: Are we there yet?
Abstract: Definitive chemoradiation (CRT) is a well-established treatment for esophageal cancer, but disease recurrence is common and many patients do not achieve initial remission with CRT alone. Predictors of outcome with CRT are needed to guide prognosis and further treatment decisions, in particular the need for post-CRT surgery. We review the role of baseline clinical factors, such as histology and tumor bulk, in predicting response to CRT. Post-CRT assessments, particularly PET imaging, may provide further information about the likelihood of complete response and survival, but the predictive power of clinical assessments remains limited. Emerging research on biomarkers holds promise for more tailored and accurate prediction of outcome with definitive CRT. © Pioneer Bioscience Publishing Company.
Keywords: cancer survival; treatment response; review; disease marker; paclitaxel; disease free survival; radiation dose; positron emission tomography; cancer grading; accuracy; carboplatin; radiotherapy; histology; preoperative period; clinical effectiveness; endoscopic biopsy; esophagus cancer; predictive value; chemoradiotherapy; esophageal cancer; endoscopic echography; response prediction; cancer prognosis; human; chemoradiation (crt)
Journal Title: Journal of Gastrointestinal Oncology
Volume: 6
Issue: 1
ISSN: 2078-6891
Publisher: Pioneer Bioscience Publishing Company  
Date Published: 2015-02-01
Start Page: 53
End Page: 59
Language: English
DOI: 10.3978/j.issn.2078-6891.2014.099
PROVIDER: scopus
PMCID: PMC4294820
PUBMED: 25642338
DOI/URL:
Notes: Review -- Export Date: 6 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karyn A Goodman
    257 Goodman
  2. Abraham Jing-Ching Wu
    401 Wu